Results 91 to 100 of about 48,854 (243)

Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer

open access: yes, 2015
Tamoxifen is the standard-of-care treatment for estrogen receptor-positive premenopausal breast cancer. We examined tamoxifen metabolism via blood metabolite concentrations and germline variations of CYP3A5, CYP2C9, CYP2C19 and CYP2D6 in 587 ...
A Ahmad   +80 more
core   +1 more source

Influence of 5-HT3bReceptor AAG Deletion Mutation and CYP2D6*10 on the Ondansetron Treatment [PDF]

open access: bronze, 2006
Ju‐Hee Kang   +7 more
openalex   +1 more source

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions

open access: yesPharmacogenomics and Personalized Medicine, 2021
Chiara Jeiziner,1 Céline K Stäuble,1,2 Markus L Lampert,1 Kurt E Hersberger,1 Henriette E Meyer zu Schwabedissen2 1Pharmaceutical Care Research Group, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland ...
Jeiziner C   +4 more
doaj  

Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study

open access: yesMalaria Journal, 2018
Background Plasmodium vivax malaria is characterized by relapses arising from the hypnozoite stages in the liver. The only currently registered drug for radical treatment to prevent relapse is primaquine.
Kanokpich Puaprasert   +7 more
doaj   +1 more source

The CYP2D6 VCF Translator [PDF]

open access: yesThe Pharmacogenomics Journal, 2016
W, Qiao   +5 more
openaire   +2 more sources

CYP2D6*2N Allele

open access: hybrid, 2020
National Cancer Institute
openalex   +1 more source

Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity

open access: yesHuman Genomics
Background Individual assessment of CYP enzyme activities can be challenging. Recently, the potato alkaloid solanidine was suggested as a biomarker for CYP2D6 activity.
Johanna I. Kiiski   +12 more
doaj   +1 more source

Variantes alélicas de CYP2D6: *4, *6 y *10 en una muestra de residentes del estado Aragua, Venezuela

open access: yesRevista Peruana de Medicina Experimental y Salud Pública
El objetivo del estudio fue determinar la frecuencia de las variantes del gen CYP2D6: *4, *6 y *10 y predecir el fenotipo metabolizador en una muestra de 145 individuos no consanguíneos, aparentemente sanos, residentes del estado Aragua, Venezuela.
Carlos Flores-Angulo   +5 more
doaj   +2 more sources

The influence of CYP2D6 genotype on trough plasma perhexiline and cis‐OH‐perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemia [PDF]

open access: bronze, 2005
Benjamin J. Davies   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy